Blood Thinner Ineffective for COVID-19 Patients: Study
A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.
Blood Thinner Ineffective for COVID-19 Patients: Study
Blood Thinner Ineffective for COVID-19 Patients: Study
A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.
A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.
More than 70,000 staff members from 150 universities are set to strike later this month, marking five consecutive years of academic protests in the country.
The Medicines and Healthcare products Regulatory Agency’s investigation comes after a study showed prenatal exposure to topiramate roughly triples a child’s likelihood of having autism or intellectual disability.
Two independent groups suggest the suite of recent unexplained hepatitis cases may stem from coinfection with an adeno-associated virus and a helper adeno- or herpesvirus, a duo which may be especially virulent in children with a particular genetic variant.
More than 100 grants previously approved for applicants in Britain have been scrapped amid a continuing dispute over the UK’s refusal to fully implement trade arrangements made when the country left the European Union.
Researchfish is a platform commonly used to track the status of grants and the impacts of research. When academics were critical of the company online, Researchfish shared these comments with the largest funding agency in the UK, and the scientists’ comments were sometimes shared with their employers.
In a statement issued by UK Research and Innovation, stem cell biologist Fiona Watt said she was devastated to learn of the impact of her actions and behavior on colleagues.
In addition to being more transmissible, the variant now dominant in the UK may be about 30 percent more deadly than previous strains, but much uncertainty remains.
A large study of UK healthcare workers finds that immunity after coronavirus infection lasts for months, but those with antibodies may still be able to carry and spread the virus upon reexposure.